Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2019-06-26 Regulatory Filings
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
US Notice of Allowance-VAL201 & Metastatic Cancer
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated June 26, 2019. It announces a 'US NOTICE OF ALLOWANCE' for patent claims related to a drug (VAL201) from the USPTO. The text explicitly states, 'This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014' and concludes with contact information provided by 'RNS, the news service of the London Stock Exchange.' This structure—a brief, material announcement distributed via the London Stock Exchange's news service (RNS)—is characteristic of a general regulatory filing that doesn't fit a more specific category like 10-K, ER, or DIV. Since it is a specific, non-standard announcement distributed through the RNS system, the most appropriate classification is the general regulatory filing category.
2019-06-26 English
Further re: Termination of Subscription Agreement
Capital/Financing Update Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates a general regulatory announcement. The content discusses the termination of a subscription agreement, settlement terms involving share issuance conditional on an upcoming AGM, and mentions 'inside information'. While it touches upon capital structure (shares) and an AGM, its primary function is to disseminate timely, material information to the market via the official regulatory news service (RNS). Since it is not a full financial report (10-K, IR), a specific financing document (CAP), or a dividend notice (DIV), the most appropriate general classification for a standard regulatory news service release is RNS.
2019-06-25 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified by the header 'RNS Number : 2138D' and contains the standard format for a 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. Although it is distributed via RNS (Regulatory News Service), the specific content dictates the classification as Major Shareholding Notification (MRQ) rather than the general RNS fallback.
2019-06-24 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with an 'RNS Number' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). However, the document is distributed via 'RNS, the news service of the London Stock Exchange' and is a regulatory filing notification. Since the content is a specific regulatory disclosure (TR-1) about a change in major holding, the most precise classification is Major Shareholding Notification (MRQ). If MRQ were not available, RNS would be the fallback, but MRQ is a better fit for the content type.
2019-06-21 English
Update on VAL201 Clinical Trial
Legal Proceedings Report Classification · 1% confidence The document begins with an 'RNS Number' and is dated June 20, 2019. It provides a 'CLINICAL UPDATE' regarding the VAL201 trial, mentioning regulatory approvals (MHRA and REC) and the appointment of a Principal Investigator. The content is a news announcement detailing operational and clinical progress, not a full financial report (like 10-K or IR) or a transcript. The presence of the RNS number and the nature of the announcement (a general update distributed via the London Stock Exchange's news service) strongly suggest a regulatory filing or announcement. Since it is a specific operational update that doesn't fit into the other specialized categories (like DIRS, DIV, CAP, etc.), the most appropriate general category for a non-standard regulatory announcement distributed via RNS is 'Regulatory Filings' (RNS). It is not an RPA because it contains substantial substantive information rather than just announcing the publication of another document.
2019-06-20 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with 'RNS Number : 7732C' and contains the standard header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which corresponds to the definition of Major Shareholding Notification. Although it is distributed via RNS, the specific content dictates the classification as Major Shareholding Notification (MRQ) rather than the general Regulatory Filing (RNS) fallback, as MRQ is a more specific category for this type of disclosure.
2019-06-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.